Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Merck’s proposal to combine two top prostate cancer drugs fails

Merck (MSD) on Tuesday announced that it will stop the Phase 3 KEYLYNK-010 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with LYNPARZA, a...

illumina launches multiple-gene test to spot rare treatable cancers

Illumina, Inc. today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal...

Pfizer, Bayer keep supplying drugs to Russia

Pfizer Inc and Bayer said on Monday they would maintain humanitarian supply of medicines to Russia, but would pull back from other non-essential spending...

Sanofi and Blackstone collaborate on 300 million euros to develop innovative treatment for multiple myeloma

Sanofi and Blackstone today announced a strategic, risk-sharing collaboration under which funds managed by Blackstone Life Sciences (BXLS) will contribute up to €300 million...

Sandoz bolsters respiratory ambitions with the acquisition of Coalesce

Sandoz, a Novartis division, announced today that it has successfully acquired the UK-based medical and drug delivery device development company, Coalesce Product Development Limited. Coalesce...

Novavax’s COVID vaccine is struggling to be rolled out in the EU

Demand for the COVID-19 vaccine produced by U.S. biotech firm Novavax has been underwhelming in the European Union's main countries in the early rollout,...
spot_img

Expert Articles

spot_img